| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Curemark, LLC Curemark, LLC is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Curemark’s pipeline includes preclinical and clinical-stage programs for the treatment of Autism, ADHD, addiction, Schizophrenia and Parkinson’s disease. Biotechnology, Research & Development, and Autism | 1 | 0 | 1 | 22 |
 | eXmoor Pharma eXmoor is a full service Cell & Gene Therapy CDMO, backed by over 20 years manufacturing experience for 150+ clients eXmoor is a full service Cell & Gene Therapy CDMO with a difference. We are backed by 20 years consultancy experience supporting over 150 organisations accelerate novel therapies from discovery to patients. We provide expert solutions at all stages of the development journey from early process development and scale-up through to GMP manufacture, fill and finish and QP release. We are open, transparent and will work with you at every step to de-risk and streamline your project and maximise the … Type: | 0 | 0 | 0 | 84 |
 | Addex Therapeutics Allosteric modulators for Human Health Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Allosteric modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecule or biological drugs. Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention. Addex's lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is poised to start a pivotal registration clinical trial … Type: | 2 | 0 | 2 | 25 |
 | BioInvent International AB BioInvent is translating cancer antibody biology into innovative immuno-oncology therapies. BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently five drug candidates in six ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors. The Company's validated, proprietary F.I.R.S.TTM technology platform identifies both targets and the antibodies that bind to them, generating many promising new immune-modulatory candidates to fuel the Company's own clinical development pipeline and providing licensing and partnering opportunities. The Company generates revenues from research collaborations … Type: | 0 | 0 | 0 | 130 |
 | Bioretec Ltd. better healing - better life Bioretec Ltd. is a medical device company focusing on the development of strong, safe and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. Our products are used worldwide, and we continue to further develop materials and products for load-bearing clinical applications. biomaterials, medical, manufacturing, medical devices, implants, absorbable metal, biopolymers, orthopaedics, and pediatric surgery Type: | 0 | 0 | 0 | 36 |
 | Mykor Mykor is a biotech company developing commercially viable and sustainable building materials grown from waste. Mykor is a biotechnology and advanced materials company working on developing sustainable materials for the construction industry as well as providing consultancy services. We work across design, engineering and life sciences to provide building materials with excellent physical properties, functional design and radical sustainability. Design, Sustainability, Manufacturing, Material Design, Building Materials, Biodesign, Consultancy, Circular Economy, Research, insulation, material development, carbon-negative, Construction Materials, Innovation , Bio-technology, Exposed insulation, Internal insulation, and Future Materials Type: | 5 | 1 | 3 | 16 |
 | Diatech Pharmacogenetics Leader in the development, production and sales of pharmacogenetics tests for cancer precision medicine. Diatech Pharmacogenetics, the leading Italian Precision Medicine company. Diatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine. The company aims at simplifying complex molecular diagnostic procedures into easy end-to-end solutions, from nucleic acids extraction and their molecular analysis, to final reporting. The company has 10 years of experience in the successful implementation of several nucleic acid analysis technologies into regulated diagnostic pipelines; examples include pyrosequencing, mass spectrometry and digital molecular barcoding. Leading cancer centres in Italy and abroad rely on Diatech CE-IVD solutions … Type: | 3 | 1 | 1 | 64 |
 | Microbiologics The world's go-to partners for infectious disease biomaterials and testing services. We are the world’s leading experts and go-to collaborators in biological products and services, focused on protecting the health and safety of people around the world. For over 50 years, we have been partnering with healthcare and life science laboratories, manufacturers and suppliers across the globe to co-create and provide biological control materials, assay services and consulting for microbiology, molecular diagnostics and virology. Headquartered in Saint Cloud, Minnesota, we have additional facilities in California, Kentucky and Michigan. Microbiology, Biotechnology, Quality Control, Molecular Microbiology, Contract Research Organization, Virology, Anti-Infective Drug … Type: | 1 | 0 | 2 | 323 |
 | MaxCyte, Inc. Let's Build Better Cells Together At MaxCyte, we pursue cell engineering excellence to maximize the potential of cells to improve patients’ lives. We have spent more than 20 years honing our expertise by building best-in-class platforms, perfecting the art of the transfection workflow, and venturing beyond today’s processes to innovate tomorrow’s solutions. Our ExPERTTM platform, which is based on our Flow Electroporation technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family … Type: | 1 | 0 | 1 | 143 |
 | BMG LABTECH Leading global manufacturer of innovative, high-quality, and reliable microplate reader instrumentation. BMG LABTECH is a leading developer and manufacturer of microplate reader instrumentation with a wide range of measurement methods. Microplate readers are used in the pharmaceutical and biotech industries, as well as in academic research establishments, for both basic research analysis and high-throughput screening. We focus solely on microplate readers and offers the most diverse selection of optical detection systems in conjunction with integrated liquid handling equipment. Our exceptional worldwide sales and support network is committed to bringing you innovative microplate reader technology with the reliability and quality that … | 3 | 0 | 0 | 95 |
 | Gilson Gilson provides high quality, dependable solutions for today's demanding liquid chromatography, solid phase extraction, liquid handling and gel permeation chromatography clean-up requirements. From the legendary PIPETMAN® products to a full range of system solutions, Gilson is the element of purification for your laboratory. Gilson has worldwide sales and service supporting the pharmaceutical, biotech, environmental, clinical, food & beverage and forensic markets. Our primary focus is on purifying samples via preparative HPLC, automated SPE or through GPC clean-up. Gilson focuses on early drug discovery and development with our preparative HPLC systems. Gilson's automated SPE systems and GPC clean-up systems support environmental, … Type: | 4 | 3 | 0 | 480 |
 | Biopredic International Biopredic International is committed to support Life Science Research by developing and distributing biological tools. We assist both academia and industries in drug development, drug discovery, cosmetic and chemical fields. Biopredic International delivers assays, tissues, cells and reagents including: > High quality hepatocytes (human and animal, fresh or cryopreserved) and other liver-derived products (microsomes, S9 fractions and cytosols) > Skin products (fresh or frozen), including human skin discs and skin sheets (full thickness, dermatomed, stratum corneum), skin cells (keratinocytes, fibroblasts), subcellular fractions... > Blood products, including whole blood, sera, plasma, PBMCs, lymphocytes, monocytes, dendritic cells, CD34... > And other products … Type: | 3 | 2 | 1 | 28 |
 | Transgene Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IOTM and myvac® Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer. | 20 | 10 | 9 | 211 |
 | HTS BIO Laboratories [Automatic translation follows] Professional hygiene itself. OUR CORE BUSINESS: BIOTECHNOLOGY APPLIED TO THE ENVIRONMENT. Since 1988, in collaboration with world-renowned research centers such as the #cnrs, HTS BIO imagines, designs and manufactures in France ecological, high-performance products and solutions at the cutting edge of innovation for #hygiene, #cleaning, bioremediation (biological depollution), agriculture, aquaculture, water treatment and water bodies. They are developed using exclusive microbiological processes and meet the highest economic and environmental requirements. AUGMENTED BIOTECHNOLOGY Do you have innovative projects? Do you want to propel innovative technology in terms of distribution and responsible consumption? Augmented biotechnology is the alliance of … Type: | 1 | 0 | 1 | 42 |
 | In-Cell-Art In-Cell-Art, is a biopharmaceutical company specializing in the preclinical and pharmaceutical development of solutions (DNA/RNA based vaccines or therapeutics) treating acquired or inherited diseases using patented bioinspired synthetic delivery systems (named Nanotaxi®) consisting of different chemical families (lipids, polymers). Its founder and research team, which includes a Nobel Laureate, have developed this unique intellectual property expertise and know-how based on 20 years of research in the field of supramolecular nucleic acids transfection agents. The vaccines and therapeutics developed by In-Cell-Art have been validated by numerous studies using infectious disease models (HIV, Flu, Dengue, dust mite, mycobacterium abscessus), therapeutic cancer models … Type: | 0 | 0 | 0 | 1 |
 | colibripeinture [Automatic translation follows] Innovation. The only biosourced and sanitizing paint that combines decoration, health and the environment! Decorating without polluting everything, that’s the idea! Healthy and natural paint for small jobs and large interior decoration projects! 196 sublime shades to reveal your interior and your offices. Innovation: biosourced AND depolluting sanitizing range. Designed from resins of 95% biosourced plant origin, its sanitizing action captures up to 80% of formaldehyde (carcinogenic pollutant contained in the air of homes, places where your children are welcomed, offices, etc.) , makes it inert. The ambient air is thus purified. It is the only paint … Type: | 5 | 2 | 2 | 5 |
 | BIOTEM First Class Antibodies & Immunoassays Your partner in immunotechnologies since 1980! Our commitment makes the difference! Expert in immunotechnology, BIOTEM is a contract Research Organisation which complies with ISO 9001:2008 quality standards. Since its establishment in 1980, the company has been the privileged partner of prestigious industrial and academic laboratories for their R&D, diagnostic and therapeutic projects. Based on a high level of expertise and exclusive technologies, BIOTEM implements the most relevant strategies for each project and is pledged to achieve the results outlined in the contract. BIOTEM advantages: - Results guaranteed - An unparalleled traceability throughout your project - Optimal quality of your product … Type: | 14 | 3 | 12 | 44 |
 |  TRIANNI, Inc an AbCellera Company Exceptional Human Antibody Discovery Technology Trianni, Inc. is a biotech company specializing in human antibody discovery platform technology. We offer the leading in vivo platform enabling efficient discovery of fully-human monoclonal antibodies. The Trianni Mouse offers biologic drug discoverers a best-in-class solution for the isolation of therapeutic antibody candidates. Benefits over older conventional mouse immunization + humanization approaches include superior lead panels with respect to potency and diversity along with speed to the clinic and lower operating costs. We aim to make Trianni’s premium technology available to any Pharma or Biotech company engaged in antibody discovery by offering flexible licenses … Type: | 0 | 0 | 0 | 1 |
 | Skye Bioscience Inc. Unlocking the pharmaceutical potential of cannabinoids Skye Bioscience (OTC:SKYE) is focused on unlocking the pharmaceutical potential of the endocannabinoid system, initially through modulation of the CB1 receptor, to treat diseases with inflammatory, fibrotic, and metabolic processes. Type: | 3 | 2 | 1 | 13 |
 | Immune Biosolutions inc. Actor of change Immune Biosolutions is a clinical stage biotech company specializing in discovering and engineering avian and human antibodies for therapeutic and diagnostic applications. Our cutting-edge techniques, including phage display and single B cell screening technologies, enable us to engineer custom-fit immunotherapeutic agents. Our discovery platform is available for biotech and pharma partners, providing access to highly conserved mammalian lineage targets and opening up new possibilities for innovative therapeutics. Our biomanufacturing capacity, which has already supported successful internal clinical trials, is also available for partners in a fee-for-service model. Our internal pipeline includes several discovery programs for various cancer … Type: | 1 | 0 | 1 | 27 |
 |  Incuvers Visualize, Connect, and Explore Every Moment of Cellular Research. Incuvers is a hardware + software company developing live cell imaging incubators for cellular researchers. Our flagship product, IRIS (Incuvers Real-time Imaging System) is the most advanced and affordable system for cell culture incubation. Combining hypoxic incubation, live cell imaging, and cloud computing, IRIS lets researchers capture time lapse videos of their entire experiments and monitor them live from anywhere, without ever taking them out of the incubator. The Incuvers mission is to “Visualize, connect, and explore every moment of cellular research”. Type: | 0 | 0 | 0 | 1 |
 | Reddot Biotech Inc. We focus on the production and sales of high quality ELISA Kits, antibodies, and molecular biology products. We focus on providing customers in the global marketplace with timely customer service, reliable supply, and products with superior quality and performance. We thrive on competition, innovation and fast resource allocation for customer needs. Reddot Biotech Inc. currently focuses on the sales of ELISA kits for pharmaceutical, laboratory, medical and scientific research use. We currently provide more than 6000 different kinds of ELISA kits. We are committed to R&D to bring customers top quality products providing accurate, reliable and fast results. With extensive … Type: | 0 | 0 | 0 | 5 |
 | Aspect Biosystems Developing bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases. bioprinting, tissue … Type: | 10 | 0 | 8 | 106 |
 | Extem Extem Bioscience has been developing advanced technologies for the use of regenerative medicines and is expanding our offerings. We have identified 3 key areas that will undergo drastic shifts over the next 10 years and are in need of a multidisciplinary evidence based approach. By collaborating and co-developing with leading institutions within North America we see a brighter, healthier and trans formative future. | 0 | 0 | 0 | 1 |
 | NURO CORP. Manufacturer of the NUOS platform allowing patients to communicate and compute by brain, instantly and without surgery. The Manufacturer of NUOS. NUOS allows any human being to communicate and compute by Brain. Instantly and without any surgery. Visit www.nuro.ca for more information. - 2017 Canada's FedDev Award Recipient. - 2018 Grand Prize Winner of 2 MIT Competitions: The MIT Future of Healthcare Hacking and the MIT Barracuda Bowl (across all Healthcare disciplines). - 2018 Canada's NRC-IRAP Award Recipient. - 2019 Province of Ontario's MaRS Discovery District Award Recipient. - 2019 Waterloo MedTech Top Start-Up Award Recipient. - 2019 Ontario Centres … | 7 | 1 | 4 | 3 |
 | Imeka We specialize in brain imaging specifically white matter, neuroinflammation, free-water and more. Imaging What Matters. Imeka is currently the only company to combine diffusion imaging and AI to map white matter integrity and get insights on neuroinflammation, demyelination and axonal loss. Therefore, with our non-invasive technology, we minimize risks for our pharma and biotech clients in the development of treatments for neurodegenerative diseases. Imeka’s main goal is to play an influential role in the search and development of cures for brain disease. Imeka’s diffusion imaging tools are able to measure extracellular water fraction (free-water), which is sensitive neuroinflammation. The technology … Type: | 2 | 0 | 1 | 17 |
 | eNUVIO - Microfabricated Devices for Next-generation Cell Culture Helping you create human-relevant in vitro models! Imagine a world where your experiments are cutting-edge, yet straightforward to perform, analyze and interpret, experiments that are time-saving, more accurate and more physiologically relevant. All this so you can get results sooner and move closer to your goal. This world is our vision! We’re committed to developing next-generation technologies for you. Powered by scientists, we design and produce innovative microfabricated devices with feature-sized components that match the dimensions of biological cells, so that you can take full advantage of emerging cell culture technologies, such as stem cells & 3D culture systems. These … Type: | 0 | 0 | 0 | 4 |
 | Telo Genomics Genomics Imaging for Precision Medicine Telo Genomics is a biotech company pioneering the most comprehensive telomere platform in the industry with powerful applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. Liquid biopsy is a rapidly growing field of significant interest to the medical community for being less invasive and more easily replicated than traditional diagnostic approaches. By combining our team’s considerable expertise in quantitative analysis of 3D telomeres with molecular biology and artificial intelligence to recognize disease-associated genetic instability, Telo Genomics is developing simple and accurate products that improve day-to-day care for … Type: | 0 | 0 | 0 | 16 |
 | Vielight Inc. Through neuroscience and engineering, we elevate brain health and performance. Through neuroscience and engineering, we elevate brain health and neural performance with our brain photobiomodulation technology. Published research with our patented technology has produced improvements in cognition, memory and mood. From neurodegeneration to brain performance, we aspire to accelerate photobiomodulation research by collaborating with bright minds globally. neurotechnology, brain photobiomodulation, biohacking, neurofeedback, brain stimulation, wellness technology, alzheimer's research, and traumatic brain injury research Type: | 0 | 0 | 0 | 16 |
 | Streamline Genomics Democratizing precision medicine Streamline Genomics is developing a platform to help clinicians and researchers benefit from genomic sequencing without the need for data analysis expertise. Type: | 4 | 1 | 3 | 2 |
 | Treventis Corporation TREVENTISTM Corporation is dedicated to treating and preventing protein misfolding diseases. We utilize a proprietary, patent-pending discovery engine – Common Conformational Morphology (CCM) – to identify druggable active sites in misfolded protein targets. CCM combines unique in silico models with deep expertise in model development (in vitro, ex vivo, in vivo) to enable rational drug design against misfolded protein targets. Our lead program focuses on anti-misfolding small molecules in tauopathy (3R, 4R, familial mutations and mixed) with relevance to Alzheimer’s disease. We have further CCM-driven efforts in oncology and other neurodegenerative diseases that show the wide utility of our technology … Type: | 0 | 0 | 0 | 16 |
 | MaSTherCell Now a part of Catalent Cell & Gene Therapy With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. … Type: | 1 | 1 | 1 | 26 |
 |  OncoDNA Genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late-stage cancer patients but also supports research and drug development in cancer and genetic diseases. Since its early days in 2012, OncoDNA has grown into a corporate group … Type: | 5 | 2 | 4 | 111 |
 | Cellaïon Cell Signaling Technology for Organ Repair and Regeneration Cell Signaling Technology for Organ Repair and Regeneration We care for liver Our advanced therapy aims to restore liver function thanks to immunomodulatory and regenerative properties of Hepastem Cell therapy, Acquired liver diseases, Liver diseases, liver based genetic diseases, NASH, ACLF, Antibodies, Clinical stage, Chronic liver disease, Fatty liver, Acute liver disease, Regenerative medicine, Biotech, and Biotechnology Type: | 2 | 1 | 1 | 51 |
 | ProDigest SHIME technology & preclinical gastrointestinal expertise We are a dynamic pre-clinical CRO offering the best-in-class in vitro simulations of the gastrointestinal tract to (functional) food, feed and pharma industry. A strong team, the desire to innovate and our customers’ satisfaction are at the core of our DNA. Our long-standing expertise and tailormade solutions support your research from early phases to the final stages of product development. ProDigest is the company that brings on the market the SHIME® platform (Simulator of the Human Intestinal Microbial Ecosystem) and related technologies (Colon-on-a-plate®; Diamod®; MetaKey®) Gastrointestinal microbial ecology, Clinical trials, Molecular analyses, In vitro … Type: | 0 | 0 | 0 | 62 |
 | Da Volterra Clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiome field. Da Volterra is a clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiota field. Our mission is to discover, develop and bring to market safe and novel therapeutic options, preserving patients’ microbiota to prevent and cure life-threatening diseases. We strive to serve patients by transforming the promise of science into innovative treatments which have the power to improve health and save lives. Committed to innovation, Da Volterra develops products intended to protect the intestinal … Type: | 0 | 0 | 0 | 7 |
 | PEPTINOV Peptinov is a biotechonology company based in Cochin Hospital (Paris, France) and founded by Prof. Jean-François Zagury to develop innovative peptide-based immunotherapies to treat chronic inflammatory diseases. Peptinov’s strategy is to induce the production of antibodies targeting self-proteins directly by the organism of the patient, through immunizations against carefully selected, highly immunogenic peptide sequences. Peptinov’s high potential R&D platform uses the tools of bioinformatics and molecular modelling to design these peptide sequences. This platform is potentially applicable to any crystallized protein and can quickly generate peptide candidates. Peptinov’s value proposition is built on its unique capability to develop anti-self proteins … Type: | 1 | 1 | 0 | 15 |
 | Depixus Depixus® is pioneering a powerful new technology based on magnetic force spectroscopy, that reveals biomolecular interactions. MAGNATM enables researchers to decode disease mechanisms and unlock a faster route to more effective therapies. Our MAGNA technology goes beyond decoding the static genetic code to reveal the dynamics of the genome that control health and disease. Single molecule analysis, RNA Drug Discovery, Protein-protein Interaction Analysis, Biophysics, Drug Discovery, Compound Screening, biomolecular interactions, and interactomics Type: | 1 | 1 | 0 | 63 |
 | Nahibu MICROBIOME PROFILING 🔬 Analyse de la flore intestinale et nutrition personnalisée. Nahibu is a leading global microbiome company offering NGS analysis, advanced analytics, and end-to-end research support. Our platform provides the most extensive metagenome and metadata catalog for data mining and microbiome association discovery. Nutrition personnalisée, Analyse du microbiote intestinal, NGS, Microbiome, and Sequencing Type: | 13 | 2 | 1 | 15 |
 | NEURON EXPERTS Neuron Experts is a Contract Research Organization (CRO) specialized in the study of neuro-active compounds. The company uses its own tests based on primary neuronal cell cultures modeling neurodegenerative diseases. With 120m2 of independent laboratory into the North Faculty of Medicine of Marseille in France, Neuron Experts is benefiting from numerous facilities and massively invested in high-tech equipment to provide the best service to clients. Type: | 0 | 0 | 0 | 9 |
 | Kolibri Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech Type: | 9 | 2 | 7 | 11 |
 | Carroucell Your CGT R&D and GMP partner. Whatever the cell you use, we have the right microcarrier for you. Tarek Fathallah, a Grenoble-based scientist and inventor, has uncovered a breakthrough in sol-gel technology with profound implications for the Healthcare industry. Driven by a passion for impactful innovation, he harnessed these properties to create tailored solutions for Cell and Gene Therapy Applications. Rooted in extensive biomanufacturing expertise, this concept addresses industry challenges by integrating cutting-edge technology into adherent cell manufacturing. Through groundbreaking research, a Microcarrier was developed, surpassing previous limitations and establishing Carroucell as a leading authority, protected by patents. In 2022, … Type: | 2 | 2 | 0 | 6 |
 | Luxia Scientific New generation microbiome diagnostics for personalised medicine Luxia Scientific is a french start-up company, leading the next wave of breakthrough personalized diagnostics. The company was started by Alessandra Cervino, former research director at Enterome. Luxia scientific is pioneering the development of novel diagnostics based on the genetic analysis of microbiomes. The company has brought to the market it’s first test in Q4 2018 and is developing two additional diagnostics. The Company is affiliated to Medicen and is supported by the BPI, Region Ile de France. Statistics, Biomarkers, Statistical genetics, qPCR, genetics, genomics, microbiome, metagenomics, nutrition, well being, health, probiotics, prebiotics, … Type: | 3 | 2 | 0 | 2 |
 | LifeScientis [Automatic translation follows] Development of Innovative Solutions for Asset Encapsulation & Toxicological Risk Assessment Strategies Our origins: ✔ Toxicologist and expert in endocrine disruption Franck Chuzel decided to launch a human-sized company aimed at “doing its part” in the collective effort to improve the well-being and health of people while respecting our planet. After 20 years spent in large industrial groups in the life sciences industry as head of security evaluation units, and having matured his business plan during his Executive MBA at EMLyon, he founded in 2015 the innovative company LifeScientis to offer two complementary services. On the one … Type: | 1 | 0 | 1 | 6 |
 | TOOPI ORGANICS [Automatic translation follows] TOOPI recycles, transforms and valorizes human urine into products for agriculture and industry. TOOPI ORGANICS collects, transforms and recycles human urine into products for agriculture and industry. A major economic and ecological issue. #urine #circulareconomy #fertilizer biotechnologies, microbiology, fertilizers, biostimulants, agriculture, gardening, distribution, recycling, start-ups, and innovation Tags: FrenchTech2030 Type: | 50 | 25 | 32 | 33 |
 | SeqOne Genomics Improves patient outcomes by making advanced genomic analysis accessible to all Founded in 2017, SeqOne Genomics headquartered in Montpellier, France, is a fast-growing deep-tech company focused on turning genomic data into medically actionable insights in oncology, rare and inherited diseases. SeqOne clinical genomic analysis platform, powered by explainable AI, provides genomic labs and healthcare professionals with best-in-class accuracy, usability, and automation seamlessly across lab technologies. By streamlining complex multi-omics analysis workflows, we pave the way for a new era of personalized healthcare at scale, where genetic testing becomes as routine as traditional blood work, radically enhancing health outcomes for all. … Type: | 8 | 5 | 5 | 79 |
 | Glowee Glowee is a biolighting systen without external energy consumption. It uses the natural ability of luminescent bacteria to produce light. Its usage is comparable to a glowing sticker and therefore it can adopt any graphical form and can for example be used on shop windows to give visibility to brands at night. Type: | 51 | 31 | 15 | 10 |
 | AQEMIA Scale Drug Discovery with Quantum-inspired Physics and AI Aqemia is a pharmatech company using quantum physics and artificial intelligence to transform the drug discovery process. With a unique proprietary technology that preclude the use of experimental data, our pipeline scales the drug discovery process at an unprecedented pace, generating an exhaustive number of new drug candidates. We are hiring! Check our career website: https://jobs.lever.co/aqemia.com Blog Posts on: https://medium.com/aqemia drug discovery, in silico drug discovery, Pharmaceutical R&D, Artificial intelligence, HPC developer, drug hunting, software developer, quantum, and drug design Tags: FrenchTech2030 Type: | 28 | 17 | 16 | 59 |
 | StemInov Births can save lives StemInov is a French Drug Discovery company working on a innovative cell based therapy in immunology Type: | 13 | 10 | 1 | 4 |
 | Antama Foundation [Automatic translation follows] New technologies in agriculture, environment and food Antama Foundation is a non-profit organization whose purpose is to promote and carry out all types of activities that contribute to making society aware of the development of Biotechnology applied to agriculture, the environment and food. In this work it has the support of several companies and institutions interested in biotechnology and improvement of seed varieties in Spain, and is open to collaboration with other entities interested in the stated purposes, as well as with the scientific community that continues to carry out carry out research in this field. Antama … Type: | 1 | 0 | 0 | 3 |
 | Dominique Dutscher A culture of service, quality, responsiveness and customisation... Founded in 1982 by M. Dominique Dutscher, our company, based in Alsace,has from the ouset specialized in the distribution of consumables and laboratory equipment for research, biotechnologies and health. Dominique Dutscher SAS has rapidly developed into expanding its catalog, multiplying its services, expanding distribution agreements with new manufacturers that have given it their confidence, by broadcasting new products on the market, paying particuliar attention to the quality of its service to its customers and to the respect of its commitments. Matériel de laboratoire, Consommables, Equipement de laboratoire, Biotechnologies, Industrie, Agroalimentaire, and Salles … | 9 | 1 | 4 | 176 |
 | Molecular Assemblies, Inc. DNA Synthesis Uncompromised Molecular Assemblies, Inc. is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented Fully Enzymatic Synthesis (or FESTM), based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably, and sustainably. FES technology will enable the reading and writing of DNA for many industries, including industrial synthetic biology and precision medicine, as well as emerging applications of nanomachines and bio-based electronics. Molecular Assemblies is headquartered in San Diego. *Fully Enzymatic Synthesis and FES are the trademarks of … Type: | 1 | 0 | 0 | 50 |
 | ONA Therapeutics We develop novel therapies against advanced cancer ONA Therapeutics is a biotech company, spin-off of ICREA and IRB, specializes in unravelling novel biology to design biopharmaceuticals attacking advanced cancer. Type: | 1 | 0 | 1 | 30 |
 | Mereo BioPharma Mereo BioPharma is a clinical-stage company focused on developing & commercialising rare disease & oncology treatments. Welcome to Mereo BioPharma, we are an agile biopharmaceutical company, focused on finding and bringing to market therapies that will improve the lives of people living with a rare disease. We are driven by a true understanding of the critical nature of our mission. We harness the power of science; with our knowledge of the rare diseases we seek to treat and deep relationships with all our stakeholders to create new therapeutic possibilities for people who need them. We do this in a focused … Type: | 3 | 0 | 2 | 43 |
 | Anima Biotech Anima is a Tech.Bio company at the intersection of mRNA biology and AI. We are advancing the mRNA Lightning platform for the discovery of small molecule mRNA drugs and novel mRNA biology targets. Built from the ground up with over a decade of expertise in mRNA biology, the platform integrates mRNA biology with AI imaging technologies to visualize the entire life cycle of mRNA in cells and decode the mRNA biology underlying a disease. Utilizing millions of images from both healthy and diseased cells, we train disease-specific mRNA image analysis neural networks to recognize a disease signature, an mRNA biology … Type: | 2 | 0 | 1 | 62 |
 | Genomadix Genomadix produces molecular tests for infectious disease, precision medicine, and water safety testing. Genomadix aims to revolutionize diagnostics—with fast, portable, and accurate DNA results. Genomadix’s diagnostic platform can go places where access to diagnostic testing may have previously been limited. Biotechnology, Personalized Medicine, Pharmacogenetics, Diagnostics, Research, Infectious Diseases, Molecular Biology, Genetic Testing, and Medical Devices Type: | 0 | 0 | 0 | 36 |
 | REGEMAT 3D Customized Bioprinting systems and Bioreactors REGEMAT3D develops #Customized #Bioprinting systems and #Bioreactors #BMAP. We create living tissue technologies. The potential of bioprinting in regenerative medicine and tissue engineering is huge. There are still many problems to be solved and many hypothesis to be tested in order to find solutions to tissue regeneration. Our mission is to develop innovative solutions in the area of bioprinting and regenerative medicine towards the clinical application of this amazing technology, to improve people ́s quality of life. bioprinting, regenerative medicine, biotechnology, and tissue engineering Type: | 3 | 0 | 1 | 22 |
 | BrainGuard Innovation for patients BrainGuard is the first company that predicts in an objective, accurate and personalized way the onset of a migraine by unobtrusive monitoring of hemodynamic signals. BrainGuard helps migraineurs letting them know in advance of the onset of a migraine to act and avoid the pain improving their quality of life. To change the paradigm of the disease, BrainGuard provides a personalized disease treatment based on prescriptions of their trusted doctor. | 5 | 1 | 3 | 3 |
 | Aptamer Group We develop Optimer® binders to enable innovation across the life science industry. Aptamer Group develops Optimer® binders to enable innovation in the life science industry. Get our newsletter: https://aptamergroup.com/newsletter Research and Development, Assay Development, Custom development, Drug development, Custom reagents, Agriculture testing, Aptamers, Biomarker discovery, Affinity ligands, Environmental testing, Affinity chromatography ligands, ADCs / AOCs, QC reagents, Diagnostic tools, and Targeted delivery Type: | 3 | 0 | 3 | 42 |
 | Synthace Helping scientists solve the world's most pressing problems with faster, more powerful experiments. Synthace is a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress. It allows biologists to design, plan, and automate experiments in a single place, then automatically gather structured experiment data and metadata in a unified no-code environment. Biotech, Life Sciences, Software, Lab Automation, Bioprocessing, Engineering Biology, and Programming Type: | 9 | 0 | 7 | 75 |
 | PBD Biotech PBD Biotech develops Actiphage, a blood test that detects 'active', disease-causing tuberculosis infection. PBD Biotech develops Actiphage, a blood test that detects 'active', disease-causing tuberculosis infection. One quarter of the world’s population is infected with latent tuberculosis (LTBI), also known as inactive tuberculosis. One in ten people with LTBI will progress to active TB disease. It is essential to develop newer diagnostic tests with significantly increased predictive value for the development of active disease among those who are infected than the currently available tests for LTBI (WHO, 2017). At PBD Biotech, our mission is to support the scale-up of latent … Type: | 8 | 1 | 3 | 15 |
 | Lifebit Revolutionising genomics & bioinformatics: unified research over distributed big data powered by AI. At Lifebit, we're pushing forward the frontiers of health and knowledge by democratising access to omics data. We enable all researchers, whether novice or advanced, to run complex analyses and generate meaningful insights fast. Lifebit CloudOS is the world’s first federated genomics platform for unified and secure research over distributed big data - wherever data resides. From top tier pharmaceutical organisations to global research institutes to genetics companies and more, Lifebit CloudOS leads the way with our best-in-class UX/UI, seamless integration to open-source tools, marketplace of proprietary … Type: | 11 | 1 | 10 | 124 |
 | Destiny Pharma plc Infection prevention biotech with late-stage assets targeting C. difficile and post-surgical S. aureus infections Destiny Pharma is a clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections. Its pipeline has novel microbiome-based biotherapeutics and XF drug clinical assets including NTCD-M3, a Phase 3 ready treatment for the prevention of C. difficile infection (CDI) recurrence which is the leading cause of hospital acquired infection in the US and also XF-73 nasal gel, which has recently completed a positive Phase 2b clinical trial targeting the prevention of post-surgical staphylococcal hospital infections including MRSA. It … Type: | 1 | 0 | 1 | 28 |
 | Viridos See how algae moves us. Viridos is a privately held biotechnology company harnessing the power of photosynthesis to create transformative solutions to mitigate climate change. Our unparalleled understanding of algal genetics and ability to translate innovation from lab to field underpins our initial deployment: a scalable platform to produce low-carbon intensity biofuels for aviation, commercial trucking, and maritime shipping. Building on a legacy of genomic firsts, our team of scientists and engineers are shaping new pathways toward a sustainable bioeconomy. To learn more, visit us at Viridos.com. Synthetic Biology, Fermentation, Next Generation Genomics, Bioprocessing, Bioinformatics, Cell Optimization, Biodiscovery, Advanced Engineering, … Type: | 5 | 0 | 5 | 90 |
 | SolasCure Transforming chronic wound care with breakthrough enzymatic technology SolasCure is developing Aurase Wound Gel, its first investigational product, which is a single, effective and easy-to-use solution with strong IP, for all elements of chronic wound care in hospitals, clinics and homes. With over 100 million patients globally suffering from chronic wounds, debridement & wound bed preparation remain a huge unmet need in the face of rising prevalence and pressured health systems. Our mission is to overcome these challenges to transform chronic wound care. Aurase Wound Gel consists of tarumase, a highly-specific fibrinolytic enzyme isolated & cloned from maggot saliva in … Type: | 2 | 1 | 1 | 19 |
 | Neumora Pioneering a new era of medicines for brain diseases Brain diseases collectively represent one of the largest areas of unmet medical need, affecting upwards of 1.5 billion patients globally. Neumora was founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our goal is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients. We’ve built a pipeline comprised of programs for neuropsychiatric disorders and neurodegenerative diseases, each targeting a novel mechanism … Type: | 1 | 0 | 1 | 132 |
 | Chromition Digital Diagnostic Solutions Digital Diagnostic Solutions | 0 | 0 | 0 | 6 |
 | ADC Therapeutics Innovating Science. Inspiring Hope. ADC Therapeutics is a commercial-stage biotechnology company improving the lives of those affected by cancer with our next-generation, targeted antibody drug conjugates (ADCs). With an ADC platform validated by the FDA approval of ZYNLONTA® and a deep understanding of the oncology treatment landscape, we are working to address significant unmet medical needs and improve outcomes for those with difficult-to-treat hematological cancers and solid tumors. Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in London (R&D), New Jersey (Clinical and Commercial), and the San Francisco Bay Area (CMC). Our highly skilled global team … Type: | 1 | 0 | 1 | 301 |
 | FUTURECO BIOSCIENCE Productos de alta calidad para la nutrición y protección de los cultivos FUTURECO BIOSCIENCE is a Spanish agrobiotechnology company based in Barcelona, dedicated to research, development, manufacturing and worldwide commercialization of effective products for the protection and nutrition of agricultural crops environmentally friendly. The mission of the company is to continue leading the industry by providing clean solutions for the challenges of the new agriculture, and to promote the use of practices and products aimed to minimize the environmental impact of this activity. Biopesticides, biotech, biostimulants, bionematicides, and soil health | 1 | 0 | 1 | 71 |
 | UK Biocentre A market-leading provider of high throughput end-to-end sample processing solutions. UK Biocentre provides a centre of excellence for biomedical research to the academic, pharmaceutical and biotech research community. UK Biocentre was established in 2011 to support the research community, by delivering automated biosample processing and storage developed from the renowned UK Biobank study involving 500,00 participants in the UK. UK Biocentre supports global biomedical research providing world class sample processing, storage and analysis services. UK Biocentre’s storage facility provides access to automated sample storage systems from the world’s leading automated storage system providers, in addition to conventional -20°C, -80°C and … Type: | 1 | 0 | 1 | 226 |
 | Bicycle Therapeutics Bicycle Precision Guided Therapeutics. Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycle is evaluating BT5528, a second-generation Bicycle Toxin Conjugate (BTCTM) targeting EphA2; BT8009, a second-generation BTC targeting Nectin-4, a well-validated tumor antigen; and BT7480, a Bicycle TICATM targeting Nectin-4 and agonizing CD137, … Type: | 6 | 2 | 1 | 274 |
 | PamGene International B.V. Offering functional Kinase activity profiling assays for signalling and biomarker research PamGene is a functional proteomics Company with a unique 3D array platform to measure the ACTIVITY of Tyrosine and Serine/Threonine kinase. We offer Products (described in our Showcase pages, PamStation-12 ®, Pamchip arrays ® and Reagent kits) and Services (lead optimization, translational/ preclinical research and biomarker discovery). We have developed powerful software tools (BioNavigator) for complex data analysis with which you can interpret results in a biological context. We support clinical trials in the oncology area. Pamgene is advancing research in Oncology as well as other areas (Neurobiology, Immunology, … Type: | 0 | 0 | 0 | 39 |
 | PROTEROS biostructures GmbH REACH RIGHT FASTER Proteros is a privately held early-stage services provider in structure-based drug discovery with a cutting-edge discovery engine tailored to unlock even the most technically challenging targets. Proteros’ work is built on scientific excellence and supports its clients to reach the right results and accelerate their overall research timelines. Proteros supports most of the world’s 20 largest pharma companies and more than 250 pharmaceutical and biotech partners in the US, Europe and Japan. For more information please visit www.proteros.com. As we continue to grow, we constantly look for committed, professional and energetic people with a high sense of … Type: | 1 | 0 | 1 | 135 |
 | Optibrium elegant software that guides successful drug discovery Optibrium provides elegant software solutions for small molecule design, optimisation and data analysis. Optibrium’s lead product, StarDropTM, is a comprehensive suite of integrated software with a highly visual and user-friendly interface. StarDropTM enables a seamless flow from the latest data through to predictive modelling and decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of the discovery process. The company’s new Augmented ChemistryTM products and services deliver ground-breaking artificial intelligence technologies that continuously learn from all available data to supplement your experience and skills. Founded in 2009, … Type: | 3 | 0 | 4 | 58 |
 | Cumulus Neuroscience Accelerating CNS Clinical Trials We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience. Type: | 4 | 0 | 3 | 48 |
 | LabGenius Combining human and machine intelligence to accelerate the discovery of advanced medicines. LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVATM). Our protein engineering platform integrates several bleeding edge technologies from the fields of machine learning, synthetic biology and robotics. Synthetic Biology, Protein Engineering, Artificial Intelligence, Machine Learning, High Throughput Screening, Medical, Health, DNA Libraries, drug discovery, and protein therapeutics Type: | 6 | 0 | 5 | 58 |
 | MediSieve Novel Biotech dual-platform: therapeutic and drug-delivery MediSieve is a London biotech start-up developing Magnetic Haemofiltration, a revolutionary platform therapy that enables the physical removal of specific substances from the bloodstream of patients. It can be used (1) as a direct treatment, (2) to increase the safety and efficacy of other therapies, or (3) to enable personalised medicine. A unique, lifesaving and often cost-saving solution, there are several multi-billion-dollar markets available for this product in oncology, infectious diseases, auto-immune diseases, poisoning, drug overdose and others. Magnetic Haemofiltration has already been shown to rapidly, specifically, and effectively remove IL-6 from human plasma. … Type: | 12 | 1 | 12 | 15 |
 | Proteintech Group New: FlexAble Antibody Labeling Kits for the ultimate flexibility in your protocol. See how it works: https://bit.ly/3N Proteintech Group - Antibodies, ELISA Kits and Proteins Every Proteintech product is manufactured and validated in-house, meaning complete control over the quality and lot-to-lot consistency of its catalog. Proteintech’s comprehensive library of original validation data, product-specific protocols, and over 130,000 product citations enables you to publish faster with reproducible results. Visit ptglab.com for more information. Proteintech Product Range: - Polyclonal and monoclonal antibodies against 13,000 targets - CoraLite fluorescent dye conjugated antibodies - ChromoTek Nanobody-based reagents - Humankine human cell-expressed proteins, cytokines, and … Type: | 4 | 0 | 3 | 175 |
 | Alligator Bioscience AB Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s portfolio includes several promising drug candidates, with the CD40 agonist mitazalimab as its key asset. Furthermore, Alligator is co-developing ALG.APV-527 with Aptevo Therapeutics Inc., several undisclosed molecules based on its proprietary technology platform, Neo-X-PrimeTM, and novel drug candidates based on the RUBYTM bispecific platform with Orion Corporation. Out-licensed programs include AC101/HLX22, in Phase 2 development, by Shanghai Henlius Biotech Inc. and an undisclosed target to Biotheus Inc. Alligator ́s technology platform comprises the proprietary technologies ALLIGATOR-GOLD® and FIND®. ALLIGATOR-GOLD® is a human antibody library containing more … Type: | 0 | 0 | 0 | 69 |
 | Mercodia Expertise that matters Mercodia utilizes its 30+ years of experience as a world-leading manufacturer of cardiometabolic immunoassays to provide tailored bioanalysis solutions for pharma and biotech companies. We specialize in assay development and validation, PK/PD, immunogenicity testing, and biomarker testing, mainly focusing on large molecules, peptides, and oligonucleotide therapeutics in preclinical and clinical development. We are GLP-certified and work in accordance with ICH GCP, EMA, and FDA guidelines. Our team of expert scientists quickly provides reproducible, reliable, and high-quality data that meets regulatory requirements. We prioritize speed and flexibility while delivering cost-effective solutions. Our vision is to improve human health … Type: | 2 | 0 | 2 | 75 |
 | Core Facility for Crystallography and Biophysics Analysis of proteins and small molecules leading to crystallization trials for academic and commercial users. The project “Core facility for crystallographic and biophysical research to support the development of medicinal products” is funded by the TEAM-TECH Core Facility programme from the Foundation for Polish Science. The project establish a Core Facility for Crystallography and Biophysics (CFCB) at the Biological and Chemical Research Centre, University of Warsaw under the supervision of Prof. dr hab. Krzysztof Woźniak (Manager) and dr eng. Jan Kutner (Deputy Manager). The mission of the Core Facility for Crystallography and Biophysics (CFCB, UW) is the analysis of proteins … Type: | 0 | 0 | 0 | 1 |
 | GenoScreen Genoscreen provides genomic services and innovative solutions in genomics. Created in 2001, GenoScreen is an innovative company specialized in the field of genomics. Using cutting-edge technologies, it analyzes and interprets information encoded in DNA to provide tailored solutions for healthcare, environment, agronomy & agriculture, agri-food, skincare, etc. Unlock the power of DNA: • Services in molecular biology analyses (DNA sequencing, genotyping, detection of gene mutation, metagenomics analysis in complex environment...) • Targeted deep sequencing-based kits for culture-free microbial diagnosis • Expertise and consultancy services for companies which develop projects in genomics GenoScreen also proposes custom-made trainings to people wishing to … | 9 | 4 | 5 | 46 |
 | DBV Technologies On a mission to advance epicutaneous immunotherapy using our innovative technology platform, ViaskinTM DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively. We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, ViaskinTM, to develop treatment options for immunologic diseases with significant unmet medical need. This mission drives our commitment to the advancement of treatments for patients and their families. That is why we are investigating a potential new class of immunotherapy, epicutaneous immunotherapy (EPIT), that aims to re-educate the … | 1 | 1 | 0 | 184 |
 | Clean Cells Solution for biologics Clean Cells is a GMP-licensed Contract Development and Manufacturing Organization providing R&D, production and quality control testing services to the biopharmaceutical industry. Our two-part site located in Western France holds an innovative process development platform, BSL2 and BSL3 GMP manufacturing laboratories and analytical areas to develop bespoke assays and perform GMP testing. Clean Cells is part of the Clean Biologics group and benefits from the additional experience of sister company Naobios, a CDMO with considerable experience in the development and manufacture of virus-based products. biosafety testing, Cell Banking and Storage, Viral Clearance, Potency Assay, R&D Contract, Training, … Type: | 7 | 2 | 7 | 122 |
 | Elicityl Glycans & Glycoconjugates expertise Elicityl is a biotechnology company based near Grenoble France within one of the largest research clusters in Glycosciences in the world. 👉🏻 Elicityl is specialized in carbohydrates design & manufacturing and has unique expertise in extraction, purification, bacterial fermentation, characterization, and analysis of carbohydrates. Our catalog of products, which is constantly evolving, includes: ✅ 200 glycans involved in key biological pathways (Cell adhesion, Immunological recognition, Embryogenesis, Oncogenesis, Infection...) ✅ Analytical references (HMOs, Malto-Oligosaccharides, Fructo-Oligosaccharides...) ✅ Polysaccharides extracted from biomass (Alginate, Ulvan, Pustulan...) ✅ Functionalized glycans ✅ Glycoconjugates ✅ Lectins We supply materials from the mg scale … Type: | 4 | 1 | 3 | 15 |
 | Greentech We source nature to resource the future. Pioneering ethical biotechnologies, from plants, marine and microbial origin. Our Credo We are biotech pioneers, we are scientists, we are explorers. Working across all continents, in all climates, in all of the worlds’ oceans. We create high-tech active ingredients from natural sources from plant, marine and microbial worlds. We source the best that nature has to offer, to the benefit of everyone: in cosmetics, healthcare, human and animal nutrition, agronomy and environment. We operate worldwide to build sustainable subsidiaries that are founded on the principles of protecting biodiversity and human relationships. No nature, … Type: | 8 | 4 | 1 | 404 |
 | GENCLIS SA The Transcription Infidelity Technology GENCLIS SA is a privately-held French Biotechnology that discovered a unique biological mechanism referred as to Transcription Infidelity (TI). Transcription Infidelity is a newly discovered and patented mechanism that incresases RNA-DNA sequence divergences (RDD). TI can lead to base substitutions, insertions and deletions. The latter cause translational frameshifts that have important consequences in determining protein immunogenicity. Genclis currently focuses on defining the effects of TI proteins translated from gapped RNA on normal and pathological humoral immunity. Type: | 0 | 0 | 0 | 5 |
 | Aureus Pharma Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researcher involved in the drug discovery and development process.The company's range of products includes … Type: | 0 | 0 | 0 | 1 |
 | Olmix Group The partner of choice for farmers towards the agro-ecological transition. Olmix Group is developing an international ecosystem of partners – farmers, integrators and distributors – to grow plants and raise animals while ensuring profitability for farmers and breeders. Algae are a key raw material which, associated with clay and trace elements through unique innovative processes, have enabled Olmix to develop concrete solutions for the worlwide agricultural transition along with improved production practices based on a wide range of scientifically proved products renowned by their efficiency. These natural solutions help farmers and breeders to undertake more respectful production strategies that not … Type: | 2 | 0 | 2 | 393 |
 | Genethon Généthon, centre de R&D préclinique et clinique de médicaments de thérapie génique. Created in 1990 and funded by AFM-TELETHON, Genethon, a pioneer in deciphering the human genome and identifying the genes associated with genetic diseases is today fully dedicated to the design and development of gene therapy treatments for rare diseases. At Genethon more than 180 scientists, clinicians and engineers specialized in gene therapy drug development, from research to the clinic, have joined forces in order to provide these innovative treatments to patients affected with rare disorders. These treatments also pave the way for new therapeutic approaches for frequent disorders. … Type: | 6 | 2 | 6 | 291 |
 | BioFeyn Better Feed. Better Fish. BioFeyn is a biotechnology company pioneering new forms of nutrient delivery to improve efficiencies in salmon farming and other sustainable nutrition markets. By working with leaders in aquaculture, agriculture, and cell-based meat, we're enabling new solutions to improve both the health of people and the planet. Type: | 6 | 0 | 5 | 4 |
 | XenTech Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 years. XenTech is Biotech/Contract Research Organization (CRO) dedicated to translational research in oncology which offers preclinical services to evaluate the anti-cancer potential of drug candidates (PDX, CDX,...) In addition, XenTech develops internal R&D programs to correlate drug response with molecular features of tumors and identify cancer biomarkers and therapeutic targets. patient-derived tumor xenograft models, oncology, biomarkers, efficacy preclinical studies, PDX, CDX, in vivo, and in-vitro assays Type: | 2 | 0 | 2 | 33 |
 | DEINOVE Investing dark biodiversity DEINOVE is a French biotechnology company pioneering the exploration of a new domain of life, unexplored at 99.9%: the microbial dark matter. By revealing the metabolic potential of rare bacteria or still classified as uncultivable, it tackles a global health and economic challenge: antimicrobial resistance. The new therapies discovered and developed by DEINOVE (antibiotics, antifungals, antivirals and antiparasitics) target superbugs (microbes that resist to one or several antimicrobials) that cause life-threatening infections which are now spreading at high speed. This breakthrough approach gave birth to one of the World first specialized micro-biotechnology platforms and a unique collection … | 2 | 1 | 1 | 17 |
 | Kantify Improving human health through Artificial Intelligence - Accelerating drug discovery in small molecules and degraders Kantify is a computational drug discovery company. We use AI to discover breakthrough therapies that change patients' lives. Our cutting-edge AI platform, Zeptomics, identifies promising drugs for any disease target, with lightning speed and unprecedented performance. Zeptomics can predict targets, hits, and ADMETox properties with groundbreaking performance. We focus on small molecules and targeted protein degraders. Contact us for a first discussion. #biotech #artificialintelligence artificial intelligence, machine learning, deep learning, drug discovery, targeted protein degraders, small molecules, target identification, and cancer Type: | 8 | 3 | 5 | 11 |
 | MOLECUBES NV Making molecular imaging available to anyone. At MOLECUBES, we believe that molecular imaging should be accessible to every research lab. It is therefore our mission to lower the barrier to preclinical PET, SPECT and CT imaging by providing compact, intuitive, flexible benchtop imaging solutions with the highest performance, supported by fast and simple workflows. With more than 100 CUBES installed worldwide, MOLECUBES is a trusted partner by your side. At MOLECUBES we provide three separate benchtop imagers or “CUBES”: The γ-CUBE is our high-resolution, high-sensitivity micro-SPECT scanner using patented collimator design. The X-CUBE is our high-throughput micro-CT scanner allowing sub-minute … Type: | 3 | 1 | 1 | 26 |
 | LIVIN farms Feeding the world while saving the planet 🐛 LIVIN farms empowers people to co-create a healthy planet through the development of insect rearing technology. We are currently working on exciting projects in professional insect breeding. | 11 | 3 | 9 | 17 |
 | VALANX Biotech Superpowering proteins. VALANX Biotech develops a proprietary technology for site-specific protein conjugation for applications in therapeutics, diagnostics and biocatalysis. Bioconjugation, Site-specific conjugation, PEGylation, Biotechnology, and Research and Development Tags: H2020 Type: | 2 | 0 | 2 | 10 |
 | BioNTech R&D (Austria) GmbH Subsidiary of BioNTech SE, now trading as BioNTech R&D (Austria). Developing novel anti-bacterials. BioNTech R&D Austria GmbH (formerly: PhagoMed Biopharma GmbH) is a fully owned subsidiary of BioNTech. The team in Vienna focuses on developing novel anti-bacterial drugs for persistent bacterial infections. Biotech Type: | 0 | 0 | 0 | 3 |
 | BIOMAKERS [Automatic translation follows] Precision Genomic Medicine and Biotechnological Platforms for Genomic Analysis & Big Data in cancer and rare diseases BIOMAKERS is a Center for Precision Genomic Medicine and Biotechnology specialized in Genomic Analysis, Big Data and development of Technology for Oncology and other complex therapeutic areas in Latin America and the USA. It has its own integrated Molecular Laboratories in Argentina, Mexico and Brazil, where biomarker studies associated with genomic-molecular diagnosis are carried out and a Big Data & Technology in San Francisco, USA. BIOMAKERS prioritizes innovation through the incorporation of new technologies through its R&D department, and the … Type: | 3 | 0 | 3 | 66 |
 | ecoLocked Turning buildings into carbon sinks. ecoLocked creates functional, CO2-negative building material additives and helps the construction industry build with climate-friendly concrete and other materials. Our products permanently sequester and store CO2 in the built environment, thereby helping you compensate residual emissions from construction projects. Moreover, they reduce the need for fossil raw materials and deliver targeted functionalities such as thermal insulation, durability, or curing time reduction. All products are based on biogenic carbon extracted from local biomass residues. Our first product, eLM Zero for climate-neutral non-structural concrete is out now in Europe! Our vision: We want to catalyze carbon removal … Type: | 7 | 4 | 3 | 20 |
SMB